tirzepatide semaglutide head to head beat in the first trial., 72 weeks: 20.2% of body weight lost vs 13.7%. Waist down about 18 cm vs 13 cm (DOI: 10.1056/NEJMoa2416394)., Why: semaglutide hits one Zepbound users lost nearly 50%

FOXO4-DRI peptide is selective in nature and exerts this potential action only on cells that have become dysfunctional over time due to aging, known as senescent cells

While the drugs role in promoting weight loss is well-established, whats particularly exciting is its potential to also reduce the frequency of HS flare-ups, contributing to the notable improvements observed in patients quality of life

She cannot face losing her mother which also means coming to terms with never having gotten what she needed from her

For individuals who wish to manage their weight whilst also addressing binge eating tendencies, the approach to creating a calorie deficit must be gradual, flexible, and psychologically informed